In may 2020, the activity of the Russian manufacturers of drugs has decreased relative to April. However, long-term growth rate has been very impressive, analysts said RNC Pharma. In total in may it produced ready-made drugs at 39.2 billion RUB, it is 30.2% more than at the end of may 2019.
In addition, in may 2020, a significant event occurred, the long-term dynamics of production of OTC categories almost on par with the pace of development of prescription drugs – up to this speaker was different in several times. So compared to may 2019 for non-prescription drugs increase in packages was 14.7%, according to a group of prescription dynamics was fixed at 14.9%. However, in total, over January-may 2020 growth rates for product categories not yet comparable, so over-the-counter category displays the long-term dynamics in packages on the 3% category of prescription drugs grew by 15.3%.